Andrew Zimmerman to Child Development Disorders, Pervasive
This is a "connection" page, showing publications Andrew Zimmerman has written about Child Development Disorders, Pervasive.
Connection Strength
1.613
-
Talalay P, Zimmerman AW. Reply to Scahill: Behavioral outcome measures in autism. Proc Natl Acad Sci U S A. 2015 Jan 27; 112(4):E350.
Score: 0.463
-
Singh K, Connors SL, Macklin EA, Smith KD, Fahey JW, Talalay P, Zimmerman AW. Sulforaphane treatment of autism spectrum disorder (ASD). Proc Natl Acad Sci U S A. 2014 Oct 28; 111(43):15550-5.
Score: 0.455
-
Close HA, Lee LC, Kaufmann CN, Zimmerman AW. Co-occurring conditions and change in diagnosis in autism spectrum disorders. Pediatrics. 2012 Feb; 129(2):e305-16.
Score: 0.377
-
Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto I. Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Pediatrics. 2014 May; 133(5):e1241-8.
Score: 0.110
-
Lance EI, York JM, Lee LC, Zimmerman AW. Association between regression and self injury among children with autism. Res Dev Disabil. 2014 Feb; 35(2):408-13.
Score: 0.107
-
Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto I. Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy. Autism Res. 2013 Jun; 6(3):149-68.
Score: 0.102